What does CUSIP 18914F103 represent in this 13F holders report?

CUSIP 18914F103 is the security identifier for CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock used to aggregate holder disclosures.

How many institutions held CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock in Q2 2022?

156 institutional investors reported CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock for Q2 2022. Use the holders table for investor-level position and value details.

CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)

CUSIP: 18914F103

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock
Shares outstanding: 416,598,522
Total 13F shares: 122,450,162
Share change: +23,614,316
Total reported value: $262,010,857
Put/Call ratio: 57%
Price per share: $2.14
Number of holders: 156
Value change: +$44,394,028
Number of buys: 85
Number of sells: 60

Quarterly Holders Quick Answers

What is CUSIP 18914F103?
CUSIP 18914F103 identifies CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 18914F103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	6.3%	26,087,528	$92,611,000	—	31 Mar 2022	13F
Chamath Palihapitiya	3/4/5	FORMER CHIEF EXECUTIVE OFFICER AND DIRECTOR, 10%+ Owner	— class O/S missing	30,147,610	$29,544,657	—	07 Jul 2021	3/4/5
BAILLIE GIFFORD & CO	13F	Company	1.9%	7,787,680	$27,646,000	—	31 Mar 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	1.8%	7,314,662	$25,967,000	—	31 Mar 2022	13F
GREENOAKS CAPITAL PARTNERS LLC	3/4/5	Other*, 10%+ Owner	— class O/S missing	25,754,556	$24,466,828	—	22 Nov 2021	3/4/5
Lee Financial Group Hawaii, Inc.	13F	Company	0%	85	$24,000,000	—	31 Mar 2022	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	1.5%	6,361,417	$22,583,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	1.4%	5,681,073	$20,168,000	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	1.1%	4,747,800	$16,855,000	—	31 Mar 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.93%	3,870,061	$13,739,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.77%	3,212,109	$11,403,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.57%	2,374,939	$8,431,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.53%	2,199,256	$7,807,000	—	31 Mar 2022	13F
Hudson Structured Capital Management Ltd.	13F	Company	0.47%	1,973,944	$7,008,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.47%	1,942,479	$6,896,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	0.46%	1,932,734	$6,861,000	—	31 Mar 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.46%	1,906,125	$6,767,000	—	31 Mar 2022	13F
HRT FINANCIAL LP	13F	Company	0.4%	1,687,223	$5,989,000	—	31 Mar 2022	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.36%	1,500,000	$5,325,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.33%	1,386,026	$4,921,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.33%	1,369,743	$4,863,000	—	31 Mar 2022	13F
JUPITER ASSET MANAGEMENT LTD	13F	Company	0.23%	965,077	$3,416,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.23%	954,800	$3,390,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.21%	854,198	$3,032,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.2%	814,875	$2,893,000	—	31 Mar 2022	13F
Qube Research & Technologies Ltd	13F	Company	0.19%	796,611	$2,828,000	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	0.17%	703,300	$2,497,000	—	31 Mar 2022	13F
Quadrature Capital Ltd	13F	Company	0.15%	624,399	$2,217,000	—	31 Mar 2022	13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	13F	Company	0.15%	609,362	$2,163,000	—	31 Mar 2022	13F
ExodusPoint Capital Management, LP	13F	Company	0.14%	567,448	$2,014,000	—	31 Mar 2022	13F
JANE STREET GROUP, LLC	13F	Company	0.12%	496,888	$1,764,000	—	31 Mar 2022	13F
GROUP ONE TRADING LLC	13F	Company	0.11%	448,949	$1,594,000	—	31 Mar 2022	13F
Comprehensive Financial Management LLC	13F	Company	0.1%	428,864	$1,522,000	—	31 Mar 2022	13F
Jump Financial, LLC	13F	Company	0.09%	364,000	$1,292,000	—	31 Mar 2022	13F
Nathaniel S. Turner	3/4/5	Director	— class O/S missing	1,324,728	$1,258,492	—	07 Jan 2021	3/4/5
BANK OF MONTREAL /CAN/	13F	Company	0.08%	340,759	$1,244,000	—	31 Mar 2022	13F
Squarepoint Ops LLC	13F	Company	0.08%	343,584	$1,220,000	—	31 Mar 2022	13F
GMT CAPITAL CORP	13F	Company	0.07%	310,800	$1,103,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.07%	282,602	$1,003,000	—	31 Mar 2022	13F
SAGE RHINO CAPITAL LLC	13F	Company	0.06%	261,500	$928,000	—	31 Mar 2022	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.06%	252,410	$896,000	—	31 Mar 2022	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.06%	246,976	$876,766	—	31 Mar 2022	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.06%	246,600	$875,000	—	31 Mar 2022	13F
OSAIC HOLDINGS, INC.	13F	Company	0.06%	244,476	$863,000	—	31 Mar 2022	13F
Invesco Ltd.	13F	Company	0.06%	230,587	$819,000	—	31 Mar 2022	13F
Bayesian Capital Management, LP	13F	Company	0.05%	211,500	$751,000	—	31 Mar 2022	13F
Summit Rock Advisors, LP	13F	Company	0.05%	210,639	$748,000	—	31 Mar 2022	13F
CREDIT SUISSE AG/	13F	Company	0.05%	199,197	$707,000	—	31 Mar 2022	13F
Paloma Partners Management Co	13F	Company	0.05%	189,680	$673,000	—	31 Mar 2022	13F
TRUIST FINANCIAL CORP	13F	Company	0.04%	163,225	$579,000	—	31 Mar 2022	13F

Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q2 2022

As of 30 Jun 2022, CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) was held by 156 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 122,450,162 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, PNC Financial Services Group, Inc., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, TWO SIGMA ADVISERS, LP, JUPITER ASSET MANAGEMENT LTD, BAILLIE GIFFORD & CO, and SUSQUEHANNA INTERNATIONAL GROUP, LLP. This page lists 157 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

147

Q2 2022 holders

156

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.